Investing.com - Financial Markets Worldwide

Saba capital management sells abrdn life sciences investors stock for $205,931

Published 07/04/2025, 17:32
Saba capital management sells abrdn life sciences investors stock for $205,931
HQL
-0.23%

Saba Capital Management, L.P., a significant shareholder of abrdn Life Sciences Investors (NYSE:HQL), has reported the sale of a portion of its holdings in the $313 million market cap company. According to InvestingPro data, HQL shares have declined nearly 10% over the past week and currently offer a substantial 16.43% dividend yield. According to a recent SEC filing, the firm sold a total of 17,210 shares over two days, amounting to $205,931. The transactions occurred on April 3 and April 4, with sale prices ranging from $11.57 to $12.23 per share. Following these sales, Saba Capital Management retains ownership of 3,124,472 shares in abrdn Life Sciences Investors. The stock currently trades at a P/E ratio of 3.67, with InvestingPro analysis indicating oversold conditions. Subscribers can access 6 additional ProTips and detailed financial metrics for HQL.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.